Age specific differences in treatment and survival of ovarian cancer patients in the province of Limburg, the Netherlands, 1986-92

International Journal of Gynecological Cancer

Volumn 8, Issue 2, 1998, Pages 150-157

  De Rijke, J M ^a   Schouten, L J ^a   Volovics, A ^a   Van Der Putten, H W H M ^a  

^a Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

Author keywords

Age; Ovarian cancer; Survival; Treatment

Indexed keywords

ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; OVARY CANCER; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0031803785     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09746.x     Document Type: Article

References (29)

1. 1 Schouten LJ, Huveneers JAM, Jager JJ, Koppejan‐Rensenbrink AG, Van den Brandt PA (eds) Incidentie van kanker in Midden‐ en Zuid‐Limburg 1992. Regionale Kankerregistratie IKL:Maastricht 1995.
2. 2 Balvert‐Locht HR, Coebergh JW, Hop WCJ, Brölman HAM, Crommelin M, Van Wijck DJAM, Verhagen‐Teulings MTh. Improved prognosis of ovarian cancer in the Netherlands during the period 1975–85: a registry‐based study. Gynecol Oncol 1991 ; 42: 3 8.
3. 3 Gloeckler Ries LA. Ovarian cancer. Survival and treatment differences by age. Cancer 1993 ; 71: 524 9.
4. 4 Cannistra SA. Cancer of the ovary. N Engl J Med 1993 ; 329: 1550 9.
5. 5 Yancik R. Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis and ortality. Cancer 1993 ; 71 (Suppl.): 517 23.
6. 6 Markman M, Lewis JL, Saigo P, Hakes T, Rubin S, Jones W, Reichman B et al. Impact of age on survival of patients with ovarian cancer. Gynecol Oncol 1993 ; 49: 236 9.
7. 7 Hightower RD, Nguyen HN, Averette HE, Hoskins W, Harrison T, Steren A. National survey of ovarian carcinoma IV: patterns of care and related survival for older patients. Cancer 1994 ; 73: 377 83.
8. 8 Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Burke TW, Morris M et al. Age contrasts in patients with advanced ovarian cancer. Cancer 1993 ; 71: 638 43.
9. 9 De Rijke JM, Schouten LJ, Schouten HC, Jager JJ, Koppejan AG, Van den Brandt PA. Age‐specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol 1996 ; 7: 677 85.
10. 10 Alberts DS, Dahlberg S, Green SJ, Garcia D, Hannigan EV, O'Toole R et al. Analysis of patient age as an independent prognostic factor for survival in a phase III study of Cisplatin‐Cyclophosphamide versus Carboplatin‐Cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. Cancer 1993 ; 71: 618 27.
11. 11 Edmonson JH, Su J, Krook JE. Treatment of ovarian cancer in elderly women. Mayo clinic‐North central cancer treatment group studies. Cancer 1993 ; 71: 615 7.
12. 12 Marchetti DL, Lele SB, Priore R, McPhee ME, Hreshchyshyn MM. Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol 1993 ; 49: 86 91.
13. 13 Thigpen T, Brady M, Omura GA, Creasman WT, McGuire WP, Hoskins WJ, Williams S. Age as a prognostic factor in ovarian carcinoma. Cancer 1993 ; 71: 606 14.
14. 14 Högberg T, Carstensen J, Simonsen E. Treatment results and prognostic factors in a population‐based study of epithelial ovarian cancer. Gynecol Oncol 1993 ; 48: 38 49.
15. 15 Levi F, Francheschi S, La Vecchia C, Ruzicka J, Gloor E, Randimbison L. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry. Switzerland Ann Oncol 1993 ; 4: 289 94.
16. 16 Koper NP, Kiemeney LALM, Massuger LFAG, Thomas CMG, Schijf CPT, Verbeek ALM. Ovarian cancer incidence (1989–91) and mortality (1954–1993) in the Netherlands. Obstet Gynecol 1996 ; 88: 387 93.
17. 17 Houwelingen JC, Bokkel Huinink WW, Van Der Burg MEL, Van Oosterom AT, Neijt JP. Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol 1989 ; 7: 769 73.
18. 18 Schouten LJ, Höppener P, Van Den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, the Netherlands. Int J Epidemiol 1993 ; 22: 369 76.
19. 19 International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 1989 ; 28: 189 90.
20. 20 Armitage P & Berry G. Statistical Methods in Medical Research. 2nd edn Oxford: Blackwell Science, 1987.
21. 21 Hakulinen T, Gibberd R, Abeywickrama K, Söderman B.A computer program package for cancer survival studies. Finnish Cancer Registry and University of Newcastle, Australia, version 2.0, 1994.
22. 22 Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monog 1961 ; 6: 101 21.
23. 23 Hakulinen T, Tentaken L, Abeywickrama K, Paivarinta L. Testing equality of relative survival patterns based on aggregate data. Biometrics 1987 ; 43: 313 25.
24. 24 Breslow NE & Day NE. Statistical methods in Cancer Research. Volume II: The design and analysis of cohort studies, 4th edn. Oxford: Oxford University Press, 1993.
25. 25 Trimbos JB (ed.) Gynaecologische oncologieklapper, 2nd edn. The Netherlands: Work Group for Gynaecological Oncology, 1995.
26. 26 Bjarnason O & Tulinius H. Tumors in Iceland. 9. Malignant Tumours Of The Ovary. A Histological Classification, Epidemiological Considerations And Survival. Acta Path Microbiol Immunol Scand Sect A 1987 ; 95: 185 92.
27. 27 Platz CE & Benda JA. Female genital tract cancer. Cancer 1995 ; 75 (Suppl): 270 94.
28. 28 Kristensen GB & Tropé C. Epithelial ovarian carcinoma. Lancet 1997 ; 349: 113 7.
29. 29 Holmes FF & Hearne E. Cancer stage‐to‐age relationship: implications for cancer screening in the elderly. J Am Geriatrics Soc 1981 ; 29: 55 7.